Fatal case of cutaneous-sparing orolaryngeal zoster in a renal transplant recipient.

about

Fatal case of cutaneous-sparing orolaryngeal zoster in a renal transplant recipient.

Item

http://www.wikidata.org/entity/Q43646903

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Fatal case of cutaneous-sparing orolaryngeal zoster in a renal transplant recipient.

@en

Fatal case of cutaneous-sparing orolaryngeal zoster in a renal transplant recipient.

@nl

type

Item

label

Fatal case of cutaneous-sparing orolaryngeal zoster in a renal transplant recipient.

@en

Fatal case of cutaneous-sparing orolaryngeal zoster in a renal transplant recipient.

@nl

prefLabel

Fatal case of cutaneous-sparing orolaryngeal zoster in a renal transplant recipient.

@en

Fatal case of cutaneous-sparing orolaryngeal zoster in a renal transplant recipient.

@nl

P1476

Fatal case of cutaneous-sparing orolaryngeal zoster in a renal transplant recipient.

@en

P2093

Elie Helou

http://www.w3.org/2001/XMLSchema#string

Jon S Morrow

http://www.w3.org/2001/XMLSchema#string

Maricar F Malinis

http://www.w3.org/2001/XMLSchema#string

Marie Landry

http://www.w3.org/2001/XMLSchema#string

Matthew Grant

http://www.w3.org/2001/XMLSchema#string

Xinyu Wu

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical immune-monitoring strategies for predicting infection risk in solid organ transplantation

Rapamycin ameliorates the CTLA4-Ig-mediated defect in CD8(+) T cell immunity during gammaherpesvirus infection.

Analysis of a single-center experience with mycophenolate mofetil based immunosuppression in renal transplantation.

Clinical practice: Herpes zoster

2013 IDSA clinical practice guideline for vaccination of the immunocompromised host.

Disseminated varicella infection in adult renal allograft recipients: four cases and a review of the literature.

A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster.

Acyclovir with and without prednisone for the treatment of herpes zoster. A randomized, placebo-controlled trial. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group.

Clinical practice. Herpes zoster.

Incidence and risk factors of herpes zoster among adult renal transplant recipients receiving universal antiviral prophylaxis.

P31

scholarly article

P356

10.1111/TID.12704

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-04-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28401625

http://www.w3.org/2001/XMLSchema#string